Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Celldex Therapeutics Other Current Assets 2010-2025 | CLDX

Celldex Therapeutics other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  
Celldex Therapeutics Annual Other Current Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Celldex Therapeutics Quarterly Other Current Assets
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.526B $0.007B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $217.340B 16.22
Amgen (AMGN) United States $160.785B 14.40
Gilead Sciences (GILD) United States $136.646B 14.19
Vertex Pharmaceuticals (VRTX) United States $120.579B 0.00
Bristol Myers Squibb (BMY) United States $95.995B 6.43
CSL (CSLLY) Australia $78.452B 0.00
GSK (GSK) United Kingdom $78.372B 9.38
Regeneron Pharmaceuticals (REGN) United States $59.158B 14.36
Alnylam Pharmaceuticals (ALNY) United States $42.091B 0.00
Argenex SE (ARGX) Netherlands $35.369B 96.32
BioNTech SE (BNTX) Germany $27.042B 0.00
Royalty Pharma (RPRX) United States $20.016B 8.46
Insmed (INSM) United States $19.842B 0.00
Biogen (BIIB) United States $18.823B 8.12
Illumina (ILMN) United States $15.349B 29.12
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $14.031B 15.73
Incyte (INCY) United States $13.401B 101.81
Moderna (MRNA) United States $12.399B 0.00
Exelixis (EXEL) United States $12.220B 20.75
BioMarin Pharmaceutical (BMRN) United States $11.198B 18.19
QIAGEN (QGEN) Netherlands $10.737B 20.89
Ascendis Pharma (ASND) Denmark $10.723B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Exact Sciences (EXAS) United States $10.124B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.917B 0.00
Blueprint Medicines (BPMC) United States $8.349B 0.00
Bio-Techne Corp (TECH) United States $8.119B 30.29
Roivant Sciences (ROIV) United Kingdom $7.845B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.561B 0.00
Legend Biotech (LEGN) United States $7.305B 0.00
Revolution Medicines (RVMD) United States $7.153B 0.00
Halozyme Therapeutics (HALO) United States $7.148B 13.68
Jazz Pharmaceuticals (JAZZ) Ireland $7.024B 6.90
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Repligen (RGEN) United States $6.728B 75.31
Anbio Biotechnology (NNNN) Germany $6.705B 0.00
TG Therapeutics (TGTX) United States $6.166B 161.83
Nuvalent (NUVL) United States $6.136B 0.00
Guardant Health (GH) United States $5.923B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.818B 0.00
Axsome Therapeutics (AXSM) United States $5.481B 0.00
Telix Pharmaceuticals (TLX) Australia $5.302B 0.00
Alkermes (ALKS) Ireland $4.815B 12.92
CRISPR Therapeutics AG (CRSP) Switzerland $4.762B 0.00
Vaxcyte (PCVX) United States $4.718B 0.00
Cytokinetics (CYTK) United States $4.619B 0.00
Metsera (MTSR) United States $4.594B 0.00
Krystal Biotech (KRYS) United States $4.337B 33.42
Akero Therapeutics (AKRO) United States $4.273B 0.00
ADMA Biologics Inc (ADMA) United States $4.223B 31.59
Avidity Biosciences (RNA) United States $4.041B 0.00
Zealand Pharma (ZLDPF) Denmark $4.016B 0.00
Zai Lab (ZLAB) China $3.940B 0.00
Merus (MRUS) Netherlands $3.911B 0.00
Scholar Rock Holding (SRRK) United States $3.907B 0.00
Arcellx (ACLX) United States $3.896B 0.00
PTC Therapeutics (PTCT) United States $3.815B 6.64
ACADIA Pharmaceuticals (ACAD) United States $3.774B 33.16
Viking Therapeutics (VKTX) United States $3.552B 0.00
Protagonist Therapeutics (PTGX) United States $3.511B 75.52
Ascentage Pharma Group - (AAPG) China $3.365B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.362B 0.00
Immunovant (IMVT) United States $3.047B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.988B 0.00
Kymera Therapeutics (KYMR) United States $2.964B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.615B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.582B 0.00
Alvotech (ALVO) Luxembourg $2.538B 14.52
Arrowhead Pharmaceuticals (ARWR) United States $2.527B 0.00
Ligand Pharmaceuticals (LGND) United States $2.501B 0.00
Apellis Pharmaceuticals (APLS) United States $2.482B 0.00
ImmunityBio (IBRX) United States $2.427B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.426B 0.00
Agios Pharmaceuticals (AGIO) United States $2.316B 0.00
Bavarian Nordic (BVNRY) Denmark $2.207B 11.66
Twist Bioscience (TWST) United States $2.198B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.191B 0.00
Denali Therapeutics (DNLI) United States $2.160B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.074B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.022B 13.44
Beam Therapeutics (BEAM) United States $2.018B 0.00
CG Oncology (CGON) United States $1.988B 0.00
Disc Medicine (IRON) United States $1.986B 0.00
Belite Bio (BLTE) United States $1.976B 0.00
IDEAYA Biosciences (IDYA) United States $1.940B 0.00
Amicus Therapeutics (FOLD) United States $1.869B 202.33
Vericel (VCEL) United States $1.869B 1237.33
NovoCure (NVCR) Jersey $1.850B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.839B 0.00
Sarepta Therapeutics (SRPT) United States $1.806B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.796B 0.00
Apogee Therapeutics (APGE) United States $1.767B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.746B 0.00
Certara (CERT) United States $1.689B 31.55
Adaptive Biotechnologies (ADPT) United States $1.645B 0.00
Janux Therapeutics (JANX) United States $1.598B 0.00
89BIO (ETNB) United States $1.552B 0.00
Vera Therapeutics (VERA) United States $1.503B 0.00
Travere Therapeutics (TVTX) United States $1.479B 0.00
Mesoblast (MESO) Australia $1.450B 0.00
ANI Pharmaceuticals (ANIP) United States $1.443B 14.87
Edgewise Therapeutics (EWTX) United States $1.435B 0.00
Viridian Therapeutics (VRDN) United States $1.370B 0.00
Biohaven (BHVN) United States $1.364B 0.00
Cogent Biosciences (COGT) United States $1.350B 0.00
GRAIL (GRAL) United States $1.317B 0.00
Dynavax Technologies (DVAX) United States $1.281B 76.21
Intellia Therapeutics (NTLA) United States $1.239B 0.00
CureVac (CVAC) Germany $1.229B 5.96
WAVE Life Sciences (WVE) Singapore $1.217B 0.00
Liquidia Technologies (LQDA) United States $1.213B 0.00
AbCellera Biologics (ABCL) Canada $1.212B 0.00
MannKind (MNKD) United States $1.204B 24.75
Pharvaris (PHVS) Netherlands $1.203B 0.00
Novavax (NVAX) United States $1.127B 2.63
Structure Therapeutics (GPCR) United States $1.124B 0.00
Praxis Precision Medicines (PRAX) United States $1.092B 0.00
Cidara Therapeutics (CDTX) United States $1.054B 0.00
Pacira BioSciences (PCRX) United States $1.046B 9.96
MiMedx (MDXG) United States $0.991B 23.96
LENZ Therapeutics (LENZ) United States $0.990B 0.00
Arcus Biosciences (RCUS) United States $0.981B 0.00
Spyre Therapeutics (SYRE) United States $0.976B 0.00
Sana Biotechnology (SANA) United States $0.976B 0.00
Replimune (REPL) United States $0.974B 0.00
Anavex Life Sciences (AVXL) United States $0.962B 0.00
Oric Pharmaceuticals (ORIC) United States $0.953B 0.00
Nurix Therapeutics (NRIX) United States $0.950B 0.00
Zymeworks (ZYME) United States $0.942B 0.00
Mineralys Therapeutics (MLYS) United States $0.933B 0.00
BGM Group (BGM) China $0.924B 0.00
Niagen Bioscience (NAGE) United States $0.906B 127.78
GH Research (GHRS) Ireland $0.900B 0.00
Jyong Biotech (MENS) Taiwan $0.891B 0.00
NeoGenomics (NEO) United States $0.889B 0.00
Immunome (IMNM) United States $0.841B 0.00
Sionna Therapeutics (SION) United States $0.816B 0.00
Geron (GERN) United States $0.809B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.796B 0.00
UniQure (QURE) Netherlands $0.790B 0.00
AnaptysBio (ANAB) United States $0.789B 0.00
Trevi Therapeutics (TRVI) United States $0.787B 0.00
Oculis Holding AG (OCS) Switzerland $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Nuvation Bio (NUVB) United States $0.759B 0.00
CorMedix Inc (CRMD) United States $0.755B 50.59
ArriVent BioPharma (AVBP) United States $0.749B 0.00
Vir Biotechnology (VIR) United States $0.748B 0.00
Immatics (IMTX) Germany $0.745B 0.00
Iovance Biotherapeutics (IOVA) United States $0.745B 0.00
Maze Therapeutics (MAZE) United States $0.712B 0.00
Pharming Group (PHAR) Netherlands $0.702B 0.00
MeiraGTx Holdings (MGTX) United States $0.697B 0.00
Gyre Therapeutics (GYRE) United States $0.695B 185.25
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.692B 0.00
Tango Therapeutics (TNGX) United States $0.688B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.671B 0.00
Urogen Pharma (URGN) United States $0.663B 0.00
Stoke Therapeutics (STOK) United States $0.650B 15.06
Autolus Therapeutics (AUTL) United Kingdom $0.649B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Dianthus Therapeutics (DNTH) United States $0.638B 0.00
Abivax SA (ABVX) France $0.627B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Keros Therapeutics (KROS) United States $0.589B 0.00
Bicara Therapeutics (BCAX) United States $0.588B 0.00
Upstream Bio (UPB) United States $0.587B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.582B 0.00
Tyra Biosciences (TYRA) United States $0.580B 0.00
Sage Therapeutics (SAGE) United States $0.572B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.562B 0.00
Rapport Therapeutics (RAPP) United States $0.555B 0.00
Arvinas (ARVN) United States $0.554B 0.00
Kura Oncology (KURA) United States $0.552B 0.00
Zenas BioPharma (ZBIO) United States $0.547B 0.00
Prime Medicine (PRME) United States $0.543B 0.00
Precigen (PGEN) United States $0.543B 0.00
Castle Biosciences (CSTL) United States $0.539B 36.63
Bicycle Therapeutics (BCYC) United Kingdom $0.539B 0.00
Septerna (SEPN) United States $0.534B 0.00
Opthea (OPT) Australia $0.525B 0.00
Celcuity (CELC) United States $0.525B 0.00
ATyr Pharma (ATYR) United States $0.520B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
Myriad Genetics (MYGN) United States $0.466B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.466B 0.00
Terns Pharmaceuticals (TERN) United States $0.460B 0.00
Rezolute (RZLT) United States $0.458B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
PureTech Health (PRTC) United States $0.447B 0.00
Fortrea Holdings (FTRE) United States $0.443B 12.25
Kamada (KMDA) Israel $0.435B 26.07
Compass Therapeutics (CMPX) United States $0.433B 0.00
Solid Biosciences (SLDB) United States $0.433B 0.00
REGENXBIO (RGNX) United States $0.426B 0.00
Fulcrum Therapeutics (FULC) United States $0.425B 0.00
Tectonic Therapeutic (TECX) United States $0.421B 0.00
MBX Biosciences (MBX) United States $0.415B 0.00
Cytek Biosciences (CTKB) United States $0.410B 0.00
Erasca (ERAS) United States $0.408B 0.00
ITeos Therapeutics (ITOS) United States $0.393B 0.00
Northwest Biotherapeutics (NWBO) United States $0.390B 0.00
Vigil Neuroscience (VIGL) United States $0.385B 0.00
Emergent Biosolutions (EBS) United States $0.379B 0.00
Gossamer Bio (GOSS) United States $0.377B 0.00
Eton Pharmaceuticals (ETON) United States $0.373B 0.00
Humacyte (HUMA) United States $0.371B 0.00
Astria Therapeutics (ATXS) United States $0.357B 0.00
Absci (ABSI) United States $0.350B 0.00
Aura Biosciences (AURA) United States $0.349B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.349B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.345B 70.12
Cartesian Therapeutics (RNAC) United States $0.344B 0.00
Candel Therapeutics (CADL) United States $0.343B 0.00
Inhibrx Biosciences (INBX) United States $0.342B 0.20
Prothena (PRTA) Ireland $0.340B 0.00
Amarin (AMRN) Ireland $0.328B 0.00
Foghorn Therapeutics (FHTX) United States $0.328B 0.00
Neurogene (NGNE) United States $0.321B 0.00
Abeona Therapeutics (ABEO) United States $0.320B 0.00
XOMA Royalty (XOMA) United States $0.318B 0.00
Inventiva S.A (IVA) France $0.318B 0.00
Palvella Therapeutics (PVLA) United States $0.314B 0.00
Olema Pharmaceuticals (OLMA) United States $0.312B 0.00
Benitec Biopharma (BNTC) United States $0.308B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.305B 0.00
Ocugen (OCGN) United States $0.304B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.302B 0.00
Atea Pharmaceuticals (AVIR) United States $0.299B 0.00
Cardiff Oncology (CRDF) United States $0.294B 0.00
Sagimet Biosciences (SGMT) United States $0.293B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.290B 0.00
Verastem (VSTM) United States $0.288B 0.00
Lifecore Biomedical (LFCR) United States $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.283B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.278B 0.00
Allogene Therapeutics (ALLO) United States $0.269B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
Vor Biopharma (VOR) $0.265B 0.00
Annexon (ANNX) United States $0.263B 0.00
Crescent Biopharma (CBIO) United States $0.257B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.255B 0.00
Aardvark Therapeutics (AARD) United States $0.252B 0.00
Monopar Therapeutics (MNPR) United States $0.251B 0.00
Kodiak Sciences (KOD) United States $0.250B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.247B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Entrada Therapeutics (TRDA) United States $0.242B 7.88
Prima BioMed (IMMP) Australia $0.240B 0.00
ScPharmaceuticals (SCPH) United States $0.239B 0.00
Editas Medicine (EDIT) United States $0.238B 0.00
Codexis (CDXS) United States $0.237B 0.00
Design Therapeutics (DSGN) United States $0.236B 0.00
Alpha Teknova (TKNO) United States $0.230B 0.00
Neumora Therapeutics (NMRA) United States $0.226B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.226B 0.00
Semper Paratus Acquisition (TVGN) United States $0.226B 0.00
MaxCyte (MXCT) United States $0.226B 0.00
Ventyx Biosciences (VTYX) United States $0.223B 0.00
Adocia (ADOCY) France $0.216B 0.00
Tvardi Therapeutics (TVRD) United States $0.213B 0.00
CARGO Therapeutics (CRGX) United States $0.213B 0.00
AC Immune (ACIU) Switzerland $0.207B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 4.98
Eupraxia Pharmaceuticals (EPRX) Canada $0.192B 0.00
GENFIT S.A (GNFT) France $0.192B 0.00
SELLAS Life Sciences (SLS) United States $0.192B 0.00
Alumis (ALMS) United States $0.187B 0.00
EnGene Holdings (ENGN) Canada $0.185B 0.00
Voyager Therapeutics (VYGR) United States $0.181B 0.00
Kyverna Therapeutics (KYTX) United States $0.176B 0.00
I-Mab (IMAB) United States $0.176B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.175B 0.00
BioStem Technologies (BSEM) $0.175B 7.11
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Agenus (AGEN) United States $0.174B 0.00
Rapt Therapeutics (RAPT) United States $0.174B 0.00
Black Diamond Therapeutics (BDTX) United States $0.173B 50.67
Puma Biotechnology (PBYI) United States $0.171B 4.47
Nuvectis Pharma (NVCT) United States $0.171B 0.00
DiaMedica Therapeutics (DMAC) United States $0.171B 0.00
Caribou Biosciences (CRBU) United States $0.170B 0.00
Instil Bio (TIL) United States $0.168B 0.00
Alpha Cognition (ACOG) Canada $0.166B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
Innate Pharma S.A (IPHA) France $0.166B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.158B 0.00
Alector (ALEC) United States $0.156B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.152B 0.00
Greenwich LifeSciences (GLSI) United States $0.150B 0.00
Molecular Partners AG (MOLN) Switzerland $0.147B 0.00
Elicio Therapeutics (ELTX) United States $0.145B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
C4 Therapeutics (CCCC) United States $0.143B 0.00
Immuneering (IMRX) United States $0.143B 0.00
Compugen (CGEN) Israel $0.141B 0.00
Spero Therapeutics (SPRO) United States $0.138B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Nkarta (NKTX) United States $0.130B 0.00
Fate Therapeutics (FATE) United States $0.130B 0.00
Seer (SEER) United States $0.125B 0.00
IO Biotech (IOBT) Denmark $0.125B 0.00
Actuate Therapeutics (ACTU) United States $0.122B 0.00
Seres Therapeutics (MCRB) United States $0.122B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Oncolytics Biotech (ONCY) Canada $0.118B 0.00
Tenaya Therapeutics (TNYA) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.116B 0.00
Genelux (GNLX) United States $0.116B 0.00
Skye Bioscience (SKYE) United States $0.114B 0.00
Citius Oncology (CTOR) United States $0.112B 0.00
Sangamo Therapeutics (SGMO) United States $0.112B 0.00
Cellectis S.A (CLLS) France $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.108B 0.00
HilleVax (HLVX) United States $0.106B 0.00
Coherus Oncology (CHRS) United States $0.104B 0.00
TuHURA Biosciences (HURA) United States $0.103B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
OKYO Pharma (OKYO) $0.100B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.100B 0.00
Contineum Therapeutics (CTNM) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Climb Bio (CLYM) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.094B 0.00
Adagene (ADAG) China $0.093B 0.00
Entera Bio (ENTX) Israel $0.093B 0.00
MiNK Therapeutics (INKT) United States $0.092B 0.00
Whitehawk Therapeutics (WHWK) United States $0.092B 0.00
XBiotech (XBIT) United States $0.091B 0.00
Connect Biopharma Holdings (CNTB) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.089B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Zura Bio (ZURA) United States $0.088B 0.00
Immunic (IMUX) United States $0.086B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.084B 0.00
Elutia (ELUT) United States $0.083B 0.00
Invivyd (IVVD) United States $0.082B 0.00
Pliant Therapeutics (PLRX) United States $0.082B 0.00
Immix Biopharma (IMMX) United States $0.082B 0.00
Oncobiologics (OTLK) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.079B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
Biomea Fusion (BMEA) United States $0.072B 0.00
Alto Neuroscience (ANRO) United States $0.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Quantum Biopharma (QNTM) Canada $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.065B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
Forte Biosciences (FBRX) United States $0.064B 0.00
Ikena Oncology (IKNA) United States $0.062B 0.00
Applied Therapeutics (APLT) United States $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
MediciNova (MNOV) United States $0.060B 0.00
ABVC BioPharma (ABVC) United States $0.060B 0.00
Renovaro (RENB) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Earth Science Tech (ETST) United States $0.058B 0.00
Artiva Biotherapeutics (ARTV) United States $0.058B 0.00
Adverum Biotechnologies (ADVM) United States $0.058B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.057B 0.00
InflaRx (IFRX) Germany $0.057B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
INmune Bio (INMB) United States $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
Celularity (CELU) United States $0.051B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Jasper Therapeutics (JSPR) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.050B 0.00
Inovio Pharmaceuticals (INO) United States $0.049B 0.00
Scilex Holding (SCLX) United States $0.049B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.046B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Exicure (XCUR) United States $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Pluri (PLUR) Israel $0.041B 0.00
KALA BIO (KALA) United States $0.038B 0.00
Cognition Therapeutics (CGTX) United States $0.038B 0.00
Generation Bio (GBIO) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
Shattuck Labs (STTK) United States $0.037B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.034B 0.00
Q32 Bio (QTTB) United States $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
CalciMedica (CALC) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
FibroBiologics (FBLG) United States $0.028B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
Ovid Therapeutics (OVID) United States $0.028B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.027B 0.00
Rani Therapeutics Holdings (RANI) United States $0.026B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.023B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Cingulate (CING) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Rallybio (RLYB) United States $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Passage Bio (PASG) United States $0.017B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Equillium (EQ) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
HOOKIPA Pharma (HOOK) United States $0.014B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.013B 0.00
Synaptogenix (TAOX) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
BioCardia (BCDA) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Artelo Biosciences (ARTL) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00